Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q4 2020 · 10-K
Revenue$74.29M$74.29M+15.1% vs Q4 2019 Net Income$7.00M$7.00M+5.8% vs Q4 2019 EPS Diluted$0.35$0.35+9.4% vs Q4 2019 Gross Profit$21,686,000+4.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$17,266,000+31.7% Free Cash Flowderived$16,782,000+29.1% Margins · derivedGross margin29.2%−2.9 pt vs Q4 2019
Operating margin11.5%−0.6 pt vs Q4 2019
Net margin9.4%−0.8 pt vs Q4 2019
ended Mar 31, 2020 · filed May 26, 2020 · 56 d after period end